Prestige Consumer Healthcare Inc. (PBH)
USD 78.79
(-1.99%)
USD 78.79
(-1.99%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1.7 Billion USD | -12.76% |
| 2023 | 1.9 Billion USD | -8.91% |
| 2022 | 2.09 Billion USD | 1.07% |
| 2021 | 2.07 Billion USD | -11.61% |
| 2020 | 2.34 Billion USD | -0.1% |
| 2019 | 2.34 Billion USD | -9.17% |
| 2018 | 2.58 Billion USD | -16.41% |
| 2017 | 3.08 Billion USD | 40.12% |
| 2016 | 2.2 Billion USD | 7.97% |
| 2015 | 2.04 Billion USD | 65.69% |
| 2014 | 1.23 Billion USD | -2.34% |
| 2013 | 1.26 Billion USD | -6.91% |
| 2012 | 1.35 Billion USD | 95.02% |
| 2011 | 695.08 Million USD | 50.34% |
| 2010 | 462.35 Million USD | -8.81% |
| 2009 | 506.99 Million USD | -11.07% |
| 2008 | 570.08 Million USD | -7.77% |
| 2007 | 618.08 Million USD | -1.77% |
| 2006 | 629.23 Million USD | 2.27% |
| 2005 | 615.28 Million USD | 207.47% |
| 2004 | 200.11 Million USD | 103.79% |
| 2003 | 98.19 Million USD | -14.83% |
| 2002 | 115.3 Million USD | 9.54% |
| 2001 | 105.26 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 1.7 Billion USD | -10.74% |
| 2024 Q4 | 1.7 Billion USD | -2.15% |
| 2024 Q1 | 1.86 Billion USD | -2.17% |
| 2024 Q2 | 1.79 Billion USD | -3.67% |
| 2024 Q3 | 1.73 Billion USD | -3.21% |
| 2023 Q4 | 1.9 Billion USD | -7.58% |
| 2023 Q3 | 2.06 Billion USD | 0.21% |
| 2023 Q2 | 2.05 Billion USD | -1.85% |
| 2023 Q1 | 2.09 Billion USD | 0.21% |
| 2023 FY | 1.9 Billion USD | -8.91% |
| 2022 Q3 | 2.14 Billion USD | -3.3% |
| 2022 Q2 | 2.21 Billion USD | 3.33% |
| 2022 Q1 | 2.14 Billion USD | 3.47% |
| 2022 Q4 | 2.09 Billion USD | -2.24% |
| 2022 FY | 2.09 Billion USD | 1.07% |
| 2021 Q2 | 2.15 Billion USD | -3.02% |
| 2021 FY | 2.07 Billion USD | -11.61% |
| 2021 Q1 | 2.22 Billion USD | -5.11% |
| 2021 Q4 | 2.07 Billion USD | -3.48% |
| 2021 Q3 | 2.14 Billion USD | -0.49% |
| 2020 Q2 | 2.35 Billion USD | -0.3% |
| 2020 Q4 | 2.34 Billion USD | 1.53% |
| 2020 FY | 2.34 Billion USD | -0.1% |
| 2020 Q1 | 2.35 Billion USD | 0.59% |
| 2020 Q3 | 2.3 Billion USD | -1.88% |
| 2019 Q1 | 2.6 Billion USD | 0.97% |
| 2019 Q2 | 2.5 Billion USD | -3.93% |
| 2019 Q3 | 2.43 Billion USD | -2.77% |
| 2019 FY | 2.34 Billion USD | -9.17% |
| 2019 Q4 | 2.34 Billion USD | -3.69% |
| 2018 Q1 | 3.04 Billion USD | -1.55% |
| 2018 FY | 2.58 Billion USD | -16.41% |
| 2018 Q4 | 2.58 Billion USD | -3.67% |
| 2018 Q3 | 2.68 Billion USD | -10.84% |
| 2018 Q2 | 3 Billion USD | -1.14% |
| 2017 FY | 3.08 Billion USD | 40.12% |
| 2017 Q4 | 3.08 Billion USD | 53.6% |
| 2017 Q3 | 2.01 Billion USD | -2.21% |
| 2017 Q2 | 2.05 Billion USD | -3.95% |
| 2017 Q1 | 2.14 Billion USD | -2.88% |
| 2016 Q3 | 1.92 Billion USD | -1.09% |
| 2016 Q2 | 1.94 Billion USD | -1.65% |
| 2016 FY | 2.2 Billion USD | 7.97% |
| 2016 Q4 | 2.2 Billion USD | 14.81% |
| 2016 Q1 | 1.97 Billion USD | -3.33% |
| 2015 Q2 | 2.13 Billion USD | 68.09% |
| 2015 Q1 | 1.26 Billion USD | 2.91% |
| 2015 Q4 | 2.04 Billion USD | -1.44% |
| 2015 FY | 2.04 Billion USD | 65.69% |
| 2015 Q3 | 2.07 Billion USD | -2.81% |
| 2014 Q3 | 1.32 Billion USD | 4.27% |
| 2014 Q1 | 1.23 Billion USD | -2.07% |
| 2014 Q2 | 1.26 Billion USD | 2.51% |
| 2014 FY | 1.23 Billion USD | -2.34% |
| 2014 Q4 | 1.23 Billion USD | -6.71% |
| 2013 Q2 | 1.34 Billion USD | 1.09% |
| 2013 FY | 1.26 Billion USD | -6.91% |
| 2013 Q4 | 1.26 Billion USD | -0.96% |
| 2013 Q3 | 1.27 Billion USD | -5.55% |
| 2013 Q1 | 1.33 Billion USD | -1.57% |
| 2012 Q1 | 670.87 Million USD | -3.48% |
| 2012 FY | 1.35 Billion USD | 95.02% |
| 2012 Q3 | 644.19 Million USD | -2.94% |
| 2012 Q2 | 663.68 Million USD | -1.07% |
| 2012 Q4 | 1.35 Billion USD | 110.42% |
| 2011 Q2 | 439.79 Million USD | 0.84% |
| 2011 Q1 | 436.11 Million USD | -5.68% |
| 2011 FY | 695.08 Million USD | 50.34% |
| 2011 Q4 | 695.08 Million USD | -0.61% |
| 2011 Q3 | 699.34 Million USD | 59.02% |
| 2010 Q1 | 493.84 Million USD | -2.59% |
| 2010 FY | 462.35 Million USD | -8.81% |
| 2010 Q4 | 462.35 Million USD | 0.14% |
| 2010 Q3 | 461.72 Million USD | -5.06% |
| 2010 Q2 | 486.32 Million USD | -1.52% |
| 2009 Q4 | 506.99 Million USD | -7.48% |
| 2009 FY | 506.99 Million USD | -11.07% |
| 2009 Q1 | 553.01 Million USD | -2.99% |
| 2009 Q2 | 547.51 Million USD | -0.99% |
| 2009 Q3 | 547.96 Million USD | 0.08% |
| 2008 Q2 | 599.16 Million USD | 0.08% |
| 2008 FY | 570.08 Million USD | -7.77% |
| 2008 Q1 | 598.68 Million USD | -3.14% |
| 2008 Q4 | 570.08 Million USD | -2.4% |
| 2008 Q3 | 584.08 Million USD | -2.52% |
| 2007 Q4 | 618.08 Million USD | 0.46% |
| 2007 Q2 | 635.65 Million USD | 1.67% |
| 2007 FY | 618.08 Million USD | -1.77% |
| 2007 Q1 | 625.2 Million USD | -0.64% |
| 2007 Q3 | 615.27 Million USD | -3.21% |
| 2006 Q2 | 623.08 Million USD | 1.53% |
| 2006 FY | 629.23 Million USD | 2.27% |
| 2006 Q1 | 613.67 Million USD | -0.26% |
| 2006 Q4 | 629.23 Million USD | -3.0% |
| 2006 Q3 | 648.7 Million USD | 4.11% |
| 2005 Q3 | 803.02 Million USD | 0.0% |
| 2005 Q4 | 615.28 Million USD | -23.38% |
| 2005 FY | 615.28 Million USD | 207.47% |
| 2004 FY | 200.11 Million USD | 103.79% |
| 2003 FY | 98.19 Million USD | -14.83% |
| 2002 FY | 115.3 Million USD | 9.54% |
| 2001 FY | 105.26 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cardinal Health, Inc. | 48.33 Billion USD | 96.479% |
| Cencora | 61.89 Billion USD | 97.25% |
| McKesson Corporation | 69.04 Billion USD | 97.535% |
| Owens & Minor, Inc. | 4.16 Billion USD | 59.181% |